FDA Approves XEOMIN, a Type of Botulinum Toxin, for Cosmetic Use
Is the third time the charm? This month the FDA approved Xeomin® (incobotulinumtoxinA) for the treatment of moderate to severe wrinkles in the glabellar region (frown lines). This is the third botulinum toxin to be approved by the FDA for cosmetic use (following Botox and Dysport). Merz Aesthetics plans to release Xeomin for use in the Spring […]
- Posted on: Jul 28 2011